Latest reported quarter: Q2, ended Jun 2026
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| -Change in Other Current Liabilities | -$30,000.00 | -$29,000.00 | $40,000.00 | -$28,000.00 | $68,000.00 |
| -Change in Other Current Assets | $0.00 | $0.00 | -$38,000.00 | – | – |
| -Change in Payables and Accrued Expense | $1.69M | $3.93M | $3.77M | -$274,000.00 | -$632,000.00 |
| -Change in Prepaid Assets | -$2.83M | $5.44M | -$11.97M | -$10.20M | -$413,000.00 |
| Change in Working Capital | -$1.17M | $9.34M | -$8.20M | -$10.54M | -$1.07M |
| Other Non-Cash Items | $25,000.00 | $26,000.00 | $21.67M | $26,000.00 | -$17,000.00 |
| Depreciation & Depletion & Amortization | $9,000.00 | $9,000.00 | $26,000.00 | $9,000.00 | $12,000.00 |
| Net Income from Continuing Operations | -$55.77M | -$40.37M | -$127.41M | -$31.93M | -$25.18M |
| Net cash flow from continuing operations | -$43.66M | -$24.08M | -$94.69M | -$33.65M | -$22.12M |
| Operating Cash Flow | -$43.66M | -$24.08M | -$94.69M | -$33.65M | -$22.12M |
| Net cash flow from investing | -$97.63M | -$8.47M | -$247.01M | -$98.16M | -$148.71M |
| Beginning Cash Balance | $55.09M | $88.44M | $69.39M | $50.11M | $220.94M |
| Ending Cash Balance | $107.25M | $55.09M | $88.44M | $88.44M | $50.11M |
| Net Other Financing Charges | $0.00 | -$840,000.00 | $171.27M | $171.12M | $0.00 |
| Proceeds from Stock Option Exercised | $2.12M | $45,000.00 | $384,000.00 | – | – |
| Net Change in Cash | $52.24M | -$33.35M | $19.07M | $38.35M | -$170.83M |
| Effect of Exchange Rate Changes | -$70,000.00 | -$7,000.00 | -$21,000.00 | -$17,000.00 | -$4,000.00 |
| Net Cash Flow from Continuing Financing Activities | $193.52M | -$795,000.00 | $360.77M | $170.16M | $0.00 |
| Financing Cash Flow | $193.52M | -$795,000.00 | $360.77M | $170.16M | $0.00 |
| Net Investment Purchase and Sale | -$97.63M | -$8.47M | -$246.78M | -$98.19M | -$148.59M |
| Free Cash Flow | -$43.66M | -$24.08M | -$94.89M | -$33.65M | -$22.18M |
| Net Cash Flow from Continuing Investing Activities | -$97.63M | -$8.47M | -$247.01M | -$98.16M | -$148.71M |
| Net PPE Purchase and Sale | – | – | -$196,000.00 | -$3,000.00 | -$57,000.00 |
| Net Other Investing Changes | – | – | -$31,000.00 | $28,000.00 | – |
| Net Issuance Payments Of Debt | – | – | $0.00 | $0.00 | – |
| Net Common Stock Issuance | – | – | $189.11M | -$1.34M | $0.00 |
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 ANNUAL | 2025 Q3 |
|---|---|---|---|---|---|
| Non-Operating Interest Income | $3.23M | $3.10M | $3.09M | $7.78M | $2.25M |
| Diluted EPS | -$0.76 | -$0.57 | -$0.65 | -$3.19 | -$0.48 |
| Basic EPS | -$0.76 | -$0.57 | -$0.65 | -$3.19 | -$0.48 |
| Net Income to Common Stockholders | -$55.77M | -$40.37M | -$31.93M | -$127.41M | -$25.18M |
| Net Income to Parent Company | -$55.77M | -$40.37M | -$31.93M | -$127.41M | -$25.18M |
| Net Profit | -$55.77M | -$40.37M | -$31.93M | -$127.41M | -$25.18M |
| Tax | $15,000.00 | $16,000.00 | – | $58,000.00 | – |
| Pretax Profit | -$55.75M | -$40.35M | -$31.87M | -$127.35M | -$25.18M |
| Other Non-Operating Income (Expenses) | -$62,000.00 | -$9,000.00 | $20,000.00 | -$21.59M | -$28,000.00 |
| Other Income (Expense) | -$62,000.00 | -$9,000.00 | $20,000.00 | -$21.59M | -$28,000.00 |
| Profit from Continuing Operations | -$55.77M | -$40.37M | -$31.93M | -$127.41M | -$25.18M |
| Operating Expense | $58.92M | $43.45M | $34.98M | $113.54M | $27.40M |
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling and Admin Expenses | $8.85M | $7.39M | $6.44M | $20.42M | $5.39M |
| -General & Admin Expense | $8.85M | $7.39M | $6.44M | $20.42M | $5.39M |
| Research & Development | $50.07M | $36.05M | $28.54M | $93.12M | $22.01M |
| Operating Profit | -$58.92M | -$43.45M | -$34.98M | -$113.54M | -$27.40M |
| Net Non-Operating Interest Income (Expense) | $3.23M | $3.10M | $3.09M | $7.78M | $2.25M |
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 ANNUAL | 2025 Q3 |
|---|---|---|---|---|---|
| Other Current Assets | $10.05M | $7.22M | $12.66M | $12.66M | $2.46M |
| Total Non-Current Assets | $862,000.00 | $916,000.00 | $965,000.00 | $965,000.00 | $1.09M |
| Net PPE | $793,000.00 | $847,000.00 | $896,000.00 | $896,000.00 | $916,000.00 |
| -Gross PPE | $793,000.00 | $847,000.00 | $896,000.00 | $896,000.00 | $916,000.00 |
| Other Non-Current Assets | $69,000.00 | $69,000.00 | $69,000.00 | $69,000.00 | $174,000.00 |
| Total Liabilities | $32.20M | $22.97M | $17.26M | $17.26M | $23.10M |
| Total Current Liabilities | $31.57M | $22.29M | $16.54M | $16.54M | $22.36M |
| Payables | $6.58M | $3.98M | $2.15M | $2.15M | $1.35M |
| -Cash and Cash Equivalents | $107.25M | $55.09M | $88.44M | $88.44M | $50.11M |
| Cash and Cash Equivalents & Short-Term Investments | $461.21M | $311.30M | $336.16M | $336.16M | $198.91M |
| Total Current Assets | $471.25M | $318.52M | $348.82M | $348.82M | $201.36M |
| Total Assets | $472.11M | $319.43M | $349.78M | $349.78M | $202.45M |
| -Accounts Payable | $6.58M | $3.98M | $2.15M | $2.15M | $1.35M |
| Current Accrued Expenses | $11.30M | $12.90M | $11.07M | $11.07M | $12.96M |
| Gains/Losses Not Affecting Retained Earnings | -$660,000.00 | -$342,000.00 | $129,000.00 | $129,000.00 | $29,000.00 |
| Additional Paid-In Capital | $711.09M | $511.55M | $506.77M | $506.77M | $321.77M |
| Other Current Liabilities | $9.77M | $2.67M | – | – | $4.95M |
| Total Non-Current Liabilities | $628,000.00 | $679,000.00 | $724,000.00 | $724,000.00 | $747,000.00 |
| Long Term Debt and Capital Lease Obligation | $628,000.00 | $679,000.00 | $724,000.00 | $724,000.00 | $747,000.00 |
| -Long Term Capital Lease Obligation | $628,000.00 | $679,000.00 | $724,000.00 | $724,000.00 | $747,000.00 |
| Total Equity | $439.92M | $296.46M | $332.52M | $332.52M | $179.35M |
| Stockholders' Equity | $439.92M | $296.46M | $332.52M | $332.52M | $179.35M |
| Capital Stock | $8,000.00 | $7,000.00 | $7,000.00 | $7,000.00 | $5,000.00 |
| -Common Stock | $6,000.00 | $5,000.00 | $5,000.00 | $5,000.00 | $3,000.00 |
| -Preferred Stock | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 |
| -Short Term Investments | $353.96M | $256.21M | $247.72M | $247.72M | $148.80M |
| Retained Earnings | -$270.52M | -$214.76M | -$174.39M | -$174.39M | -$142.46M |
| Convertible preferred securities | – | – | $0.00 | $0.00 | $0.00 |
No comments yet — be the first to weigh in on JBIO.